Anaphylaxis: Office Management and Prevention

Immunology and Allergy Clinics of North America

Volumn 27, Issue 2, 2007, Pages 177-191

  Oswalt, Matthew L ^a   Kemp, Stephen F ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID DERIVATIVE; DIPHENHYDRAMINE; DOPAMINE; GLUCAGON; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPERTENSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; RANITIDINE; SALBUTAMOL; SODIUM CHLORIDE;

ANAPHYLAXIS; BASOPHIL; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG MEGADOSE; DRUG USE; FLUID RESUSCITATION; FOLLOW UP; FOOD INTAKE; HEALTH CARE PERSONNEL; HUMAN; HYPOTENSION; INSECT STING; LOADING DRUG DOSE; LOW DRUG DOSE; MAST CELL; MEDICAL PRACTICE; MONOTHERAPY; MORTALITY; OXYGEN THERAPY; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK MANAGEMENT;

ANAPHYLAXIS; BRONCHODILATOR AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; EPINEPHRINE; FOOD HYPERSENSITIVITY; HUMANS; OFFICE MANAGEMENT; OFFICE VISITS; SYNCOPE, VASOVAGAL;

EID: 34247605912     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2007.03.004     Document Type: Review

References (46)

1. Sampson H.A., Munoz-Furlong A., Campbell R.L., et al. Second symposium on the definition and management of anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117 (2006) 391-397
2. Kemp S.F., and Lockey R.F. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110 (2002) 341-348
3. Valentine M., Frank M., Friedland L., et al. Allergic emergencies. In: Drause R.M. (Ed). Asthma and other allergic diseases. NIAID Task Force Report (1979), National Institutes of Health, Bethesda (MD) 467-507
4. Yocum M.W., Butterfield J.H., Klein J.S., et al. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 104 (1999) 452-456
5. Neugat A.I., Ghatak A.T., and Miller R.L. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 161 (2001) 15-21
6. Simons F.E., Peterson S., and Black C.D. Epinephrine dispensing for the out-of-hospital treatment of anaphylaxis in infants and children: a population-based study. Ann Allergy Asthma Immunol 86 (2001) 622-626
7. Simons F.E., Peterson S., and Black C.D. Epinephrine-dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 110 (2002) 647-651
8. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction?. Curr Opin Allergy Clin Immunol 4 (2004) 285-290
9. Fisher M. Clinical observations on the pathophysiology and implications for treatment. In: Vincent J.L. (Ed). Update in intensive care and emergency medicine (1989), Springer-Verlag, New York 309-316
10. Fisher M.M. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 14 (1986) 17-21
11. Kovanen P.T., Kaartinen M., and Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92 (1995) 1084-1088
12. Kounis N.G. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm?. Int J Cardiol 110 (2006) 7-14
13. Steffel J., Akhmedov A., Greutert H., et al. Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation 112 (2005) 341-349
14. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 95 (2005) 217-226
15. Brazil E., and MacNamara A.F. Not so immediate hypersensitivity: the danger of biphasic anaphylactic reactions. J Accid Emerg Med 15 (1998) 252-253
16. Ellis A.K., and Day J.H. Biphasic anaphylaxis: a prospective examination of 103 patients for the incidence and characteristics of biphasic reactivity. [abstract]. J Allergy Clin Immunol 113 (2004) S259
17. Stark B.J., and Sullivan T.J. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 78 (1986) 76-83
18. Sampson H.A., Mendelson L., and Rosen J.P. Fatal and near-fatal food anaphylaxis reactions in children. N Engl J Med 327 (1992) 380-384
19. LaRoche D., Vergnaud M., Sillard B., et al. Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase. Anesthesiology 75 (1991) 945-949
20. Brown S.G.A., Blackman K.E., Stenlake V., et al. Insect sting anaphylaxis: prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 21 (2004) 149-154
21. Smith P.L., Kagey-Sobotka A., Bleecker E.R., et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 66 (1980) 1072-1080
22. Lieberman P., Kemp S.F., Oppenheimer J., et al. Joint task force on practice parameters. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115 (2005) S483-S523
23. Project Team of the Resuscitation Council (UK). Emergency medical treatment of anaphylactic reactions. J Accid Emerg Med 16 (1999) 243-247
24. Cummins RO, Hazinski MR, Baskett PJF, et al, editors. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: an international consensus on science. American Heart Association in collaboration with the International Liaison Committee on Resuscitation (ILCOR). Part 8: advanced challenges in resuscitation. Section 3: special challenges in ECC. Anaphylaxis. Circulation 2000;102(Suppl I):I241-3.
25. American Heart Association in collaboration with International Liaison Committee on Resuscitation. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Anaphylaxis. Circulation 112 Suppl IV (2005) IV143-IV145
26. Soar J., Deakin C.D., Nolan J.P., et al. European Resuscitation Council guidelines for resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resuscitation 67 Suppl 1 (2005) S135-S170
27. Gompels L.L., Bethune C., Johnston S.L., et al. Proposed use of adrenaline (epinephrine) in anaphylaxis and related conditions: a study of senior house officers starting accident and emergency posts. Postgrad Med J 78 (2002) 416-418
28. Clark S., Bock S.A., Gaeta T.H., et al. Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol 113 (2004) 347-352
29. Haymore B.R., Carr W.W., and Frank W.T. Anaphylaxis and epinephrine prescribing patterns in a military hospital: underutilization of the intramuscular route. Allergy Asthma Proc 26 (2005) 361-365
30. Board of Directors. American Academy of Allergy and Immunology. Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergenic extracts [position statement]. J Allergy Clin Immunol 93 (1994) 811-812
31. WHO Position Paper. Allergen immunotherapy. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53 (1998) S1-S42
32. Caroline N.L. Emergency care in the streets. 2nd edition (1983), Little, Brown, Boston p. 57-98
33. Pumphrey R.S. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 112 2 (2003) 451-452
34. AAAAI Board of Directors. The use of epinephrine in the treatment of anaphylaxis. J Allergy Clin Immunol 94 (1994) 666-668
35. Simons F.E.R., Roberts J.R., Gu X., et al. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 101 (1998) 33-37
36. Simons F.E.R., Gu X., and Simons K.J. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 108 (2001) 871-873
37. Song T.T., Nelson M.R., Chang J.H., et al. Adequacy of the epinephrine auto-injector needle length in delivering epinephrine to the intramuscular tissues. Ann Allergy Asthma Immunol 94 (2005) 539-542
38. Barach E.M., Nowak R.M., Lee T.G., et al. Epinephrine for treatment of anaphylactic shock. JAMA 251 (1984) 2118-2122
39. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol 3 (2003) 313-318
40. Westfall T.C., and Westfall D.P. Adrenergic agonists and antagonists. In: Brunton L.L. (Ed). Goodman and Gilman's the pharmacological basis of therapeutics. 11th edition (2006), McGraw-Hill, New York 215-268
41. Toogood J.H. Beta blocker therapy and the risk of anaphylaxis. Can Med Assoc J 136 (1987) 929-933
42. Lang D.M. Anaphylactoid and anaphylactic reactions. Hazards of B blockers. Drug Saf 12 (1995) 299-304
43. Toogood J.H. Risks of anaphylaxis in patients receiving beta blocker drugs. [editorial]. J Allergy Clin Immunol 81 (1988) 1-5
44. Pollack C.V. Utility of glucagon in the emergency department. J Emerg Med 11 (1993) 195-205
45. Sherman M.S., Lazar E.J., and Eichacker P. A bronchodilator action of glucagon. J Allergy Clin Immunol 81 (1988) 908-911
46. Thomas M., and Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta blockers. Emerg Med J 22 (2005) 272-273